346 related articles for article (PubMed ID: 15337640)
1. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials.
Gijsman HJ; Geddes JR; Rendell JM; Nolen WA; Goodwin GM
Am J Psychiatry; 2004 Sep; 161(9):1537-47. PubMed ID: 15337640
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis.
Sidor MM; Macqueen GM
J Clin Psychiatry; 2011 Feb; 72(2):156-67. PubMed ID: 21034686
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.
McGirr A; Vöhringer PA; Ghaemi SN; Lam RW; Yatham LN
Lancet Psychiatry; 2016 Dec; 3(12):1138-1146. PubMed ID: 28100425
[TBL] [Abstract][Full Text] [Related]
4. Antidepressants for bipolar disorder: A meta-analysis of randomized, double-blind, controlled trials.
Zhang Y; Yang H; Yang S; Liang W; Dai P; Wang C; Zhang Y
Neural Regen Res; 2013 Nov; 8(31):2962-74. PubMed ID: 25206617
[TBL] [Abstract][Full Text] [Related]
5. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
Leverich GS; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Kupka RW; Denicoff KD; Nolen WA; Grunze H; Martinez MI; Post RM
Am J Psychiatry; 2006 Feb; 163(2):232-9. PubMed ID: 16449476
[TBL] [Abstract][Full Text] [Related]
6. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
7. Rational polypharmacy in the bipolar affective disorders.
Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
[TBL] [Abstract][Full Text] [Related]
8. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
[TBL] [Abstract][Full Text] [Related]
9. Clinical inquiries: what drugs are best for bipolar depression?
Ukaegbu C; Banks JB; Carter NJ; Goldman LS
J Fam Pract; 2008 Sep; 57(9):606-8. PubMed ID: 18786334
[TBL] [Abstract][Full Text] [Related]
10. The use of antidepressants in bipolar disorder.
Salvi V; Fagiolini A; Swartz HA; Maina G; Frank E
J Clin Psychiatry; 2008 Aug; 69(8):1307-18. PubMed ID: 18681751
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of long-term antidepressant treatment in bipolar disorder.
Ghaemi SN; Lenox MS; Baldessarini RJ
J Clin Psychiatry; 2001 Jul; 62(7):565-9. PubMed ID: 11488370
[TBL] [Abstract][Full Text] [Related]
12. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
[TBL] [Abstract][Full Text] [Related]
14. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review.
Altshuler L; Kiriakos L; Calcagno J; Goodman R; Gitlin M; Frye M; Mintz J
J Clin Psychiatry; 2001 Aug; 62(8):612-6. PubMed ID: 11561933
[TBL] [Abstract][Full Text] [Related]
15. Antidepressants for bipolar depression.
Hirschfeld RM; Fochtmann LJ; McIntyre JS
Am J Psychiatry; 2005 Aug; 162(8):1546-7; author reply 1547-8. PubMed ID: 16055788
[No Abstract] [Full Text] [Related]
16. New approaches in managing bipolar depression.
Keck PE; McElroy SL
J Clin Psychiatry; 2003; 64 Suppl 1():13-8. PubMed ID: 12625800
[TBL] [Abstract][Full Text] [Related]
17. Bipolar depression: management options.
Malhi GS; Mitchell PB; Salim S
CNS Drugs; 2003; 17(1):9-25. PubMed ID: 12467490
[TBL] [Abstract][Full Text] [Related]
18. Demographic variables, design characteristics, and effect sizes of randomized, placebo-controlled, monotherapy trials of major depressive disorder and bipolar depression.
Papakostas GI; Martinson MA; Fava M; Iovieno N
J Clin Psychiatry; 2016 May; 77(5):e619-24. PubMed ID: 27249092
[TBL] [Abstract][Full Text] [Related]
19. The treatment of bipolar depression.
Compton MT; Nemeroff CB
J Clin Psychiatry; 2000; 61 Suppl 9():57-67. PubMed ID: 10826663
[TBL] [Abstract][Full Text] [Related]
20. Reevaluating therapies for bipolar depression.
Grunze H
J Clin Psychiatry; 2005; 66 Suppl 5():17-25. PubMed ID: 16038598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
